August 31, 2015
GlaxoSmithKline K.K. (GSK) made payments totaling roughly 9.34 billion yen to medical institutions and doctors in 2014, according to data released by the company under industry guidelines on August 28. The drug maker booked 5,093 million yen for R&D, including...read more